Live birth rate · patients with adhesion prevention after gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adhesion score · patients with adhesion prevention after gynaecological surgery
1 finding from 1 review
Incidence of adhesions ‐ de novo Incidence at second‐look laparoscopy · patients with adhesion prevention after gynaecological surgery
Analysis 7 ‐ Collagen membrane with polyethylene glycol and glycerol may leads to lower incidence of adhesions ‐ de novo Incidence at second‐look laparoscopy compared with ringer's lactate (low certainty).
1 finding from 1 review
Incidence of adhesions ‐ re‐formation (or mixture) Incidence at second‐look laparoscopy · patients with adhesion prevention after gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Operating time · women with uterine fibroids
3 findings from 1 review
no estimate extracted
6 studies · 443 participants
Very low
no estimate extracted
1 study · 39 participants
Low
no estimate extracted
6 studies · 617 participants
Low
Intraoperative blood loss (mL) · women with uterine fibroids
3 findings from 1 review
Blood transfusion · women with uterine fibroids
GnRHa treatment showed no clear difference in blood transfusions compared with no pretreatment or placebo before myomectomy (operative and… (low certainty).
3 findings from 1 review
Overall postoperative morbidity · women with uterine fibroids
GnRHa treatment showed no clear difference in postoperative morbidity compared with no pretreatment or placebo before myomectomy (operative and… (low certainty).
3 findings from 1 review
Adverse events · women with uterine fibroids
GnRHa treatment probably leads to higher adverse events compared with placebo or no pretreatment (preoperative outcomes) (moderate certainty).
1 finding from 1 review
OHSS · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
OHSS rate (Oestr + Ant vs Ant) · ovarian stimulation protocols for women undergoing ART
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
OHSS · ovarian stimulation protocols for women undergoing ART
It is very uncertain whether oestrogen changes OHSS rate (Oestr + Ant vs Ag) compared with no pretreatment (very low certainty).
1 finding from 1 review
OHSS · women undergoing assisted reproduction
Combined oral contraceptive pill showed no clear difference in OHSS rate (COCP + Ant vs Ant) compared with no pretreatment (low certainty).
2 findings from 1 review
Symptom scores over 2 to 4 menstrual cycles1 · women with PMS
1 finding from 1 review
Withdrawals due to adverse events · women with PMS
It is very uncertain whether oestrogen in combination with progestogen (sequential or continuous) changes withdrawal due to adverse events over 2 to 4 menstrual cycles1 compared with placebo (very low certainty).
1 finding from 1 review
Specific adverse events · women with PMS
It is very uncertain whether oestrogen in combination with progestogen (sequential or continuous) changes specific adverse events over 2 to 4 menstrual cycles1 compared with placebo (very low certainty).
1 finding from 1 review
no estimate extracted
206 participants
Very low
Global symptoms of PMS over 3 menstrual cycles1 · women with PMS
1 finding from 1 review
Withdrawals due to adverse events · women with PMS
1 finding from 1 review
Specific adverse events · women with PMS
1 finding from 1 review
Withdrawals due to adverse events · women with PMS
It is very uncertain whether dose comparison: oestrogen 100 µg patch changes adverse events ‐ withdrawal rates over 8 months' compared with 200 µg patch plus progestogen (very low certainty).
1 finding from 1 review